LeMaitre Vascular, Inc. (LMAT)
NASDAQ: LMAT · Real-Time Price · USD
83.15
-0.48 (-0.57%)
Jun 11, 2025, 4:00 PM - Market closed
LeMaitre Vascular Stock Forecast
Stock Price Forecast
According to 6 professional analysts, the 12-month price target for LeMaitre Vascular stock ranges from a low of $93 to a high of $110. The average analyst price target of $100.67 forecasts a 21.07% increase in the stock price over the next year.
Price Target: $100.67 (+21.07%)
Analyst Consensus: Buy
* Price targets were last updated on Feb 28, 2025.
Analyst Ratings
The average analyst rating for LeMaitre Vascular stock is "Buy". This means that analysts believe this stock is likely to outperform the market over the next twelve months.
Recommendation Trends
| Rating | Dec '24 | Jan '25 | Feb '25 | Mar '25 | Apr '25 | May '25 |
|---|---|---|---|---|---|---|
| Strong Buy | 2 | 2 | 4 | 4 | 4 | 3 |
| Buy | 3 | 3 | 1 | 1 | 1 | 1 |
| Hold | 2 | 2 | 3 | 3 | 3 | 3 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 7 | 7 | 8 | 8 | 8 | 7 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| Lake Street | Lake Street | Strong Buy Maintains $105 → $110 | Strong Buy | Maintains | $105 → $110 | +32.29% | Feb 28, 2025 |
| Citizens Capital Markets | Citizens Capital Markets | Strong Buy Maintains $105 → $110 | Strong Buy | Maintains | $105 → $110 | +32.29% | Feb 28, 2025 |
| Barrington Research | Barrington Research | Buy → Hold Downgrades n/a | Buy → Hold | Downgrades | n/a | n/a | Feb 28, 2025 |
| Wells Fargo | Wells Fargo | Hold Initiates $95 | Hold | Initiates | $95 | +14.25% | Feb 13, 2025 |
| Oppenheimer | Oppenheimer | Buy Reiterates $90 → $93 | Buy | Reiterates | $90 → $93 | +11.85% | Nov 1, 2024 |
Financial Forecast
Revenue This Year
250.38M
from 219.86M
Increased by 13.88%
Revenue Next Year
272.44M
from 250.38M
Increased by 8.81%
EPS This Year
2.21
from 1.93
Increased by 14.53%
EPS Next Year
2.46
from 2.21
Increased by 11.12%
Historical EPS numbers are GAAP, while forecasted numbers may be non-GAAP.
Revenue Forecast
| Revenue | 2025 | 2026 | 2027 | 2028 | 2029 |
|---|---|---|---|---|---|
| High | 260.3M | 291.5M | 326.5M | ||
| Avg | 250.4M | 272.4M | 300.0M | ||
| Low | 237.6M | 250.9M | 272.1M |
Revenue Growth
| Revenue Growth | 2025 | 2026 | 2027 | 2028 | 2029 |
|---|---|---|---|---|---|
| High | 18.4% | 16.4% | 19.8% | ||
| Avg | 13.9% | 8.8% | 10.1% | ||
| Low | 8.0% | 0.2% | -0.1% |
EPS Forecast
| EPS | 2025 | 2026 | 2027 | 2028 | 2029 |
|---|---|---|---|---|---|
| High | 2.35 | 2.65 | 3.05 | ||
| Avg | 2.21 | 2.46 | 2.69 | ||
| Low | 2.06 | 2.22 | 2.40 |
EPS Growth
| EPS Growth | 2025 | 2026 | 2027 | 2028 | 2029 |
|---|---|---|---|---|---|
| High | 21.9% | 19.7% | 24.0% | ||
| Avg | 14.5% | 11.1% | 9.7% | ||
| Low | 6.6% | 0.6% | -2.3% |
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.